To: Sandy Walsh <firstname.lastname@example.org>
Subject: Establishing the Validity of Pediatric Bipolar Disorder
Dear Miss Walsh,
I am a professional educator, software architect, and a doctoral candidate at Columbia University’s School of Journalism. I am outraged that the FDA is abusing its power and violating the public trust by supporting the corporate interests of the pharmaceutical lobby. The drug companies are shamefully maneuvering to expand the market for the multi-billion dollar a year anti-psychotic industry by extending the diagnostic criteria of the purported mental illnesses their toxic pills are prescribed to treat.
The FDA has recently taken the unprecedented action of effectively legislating the existence of a disease, a disease whose existence is denied by many experts on both mind and body. The diagnosis of Pediatric Bipolar Disorder does not exist in the DSM IV, is not recognized by public or private insurance companies, and is the subject of intense debate between psychiatrists, psychologists, social workers, and therapists. When did the FDA become authorized to construct/validate new diagnoses or decide who is mentally ill?
I have been closely following the heated controversy surrounding the diagnosis of Bipolar Disorder in children since the tragic death of Rebecca Riley. Rebecca was diagnosed with Bipolar disorder at 2 years old, and was killed when she was 4 by an overdose of anti-psychotics. This past year, Frontline aired The Medicated Child, a provocative investigation of the widespread experiment being conducted on the innocent children of America. I beg you to watch this documentary before making any more decisions about the existence of this alleged disorder. The piece demonstrates how our children are being chemically swaddled, and how these drugs are being systematically deployed as instruments of discipline and control.
The public has a right to full disclosure on this important matter of public health! I am shocked that you have still not issued a statement explaining your position on Pediatric Bipolar Disorder – What behavioural symptoms constitute this alleged disease, and how were these criteria arrived at? What is the progression of this illness and what are the mechanisms are involved in its treatment? Who was consulted in the validation of this disease, and have their research findings been vetted by a disinterested scientific community?
The FDA’s complicit involvement in a mass experiment on an entire generation of American children demands transparent accounting. It is absolutely imperative that the FDA shine some light on its backroom dealings with the Big Pharma.